Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients
about
Melanoma NOS1 expression promotes dysfunctional IFN signalingNovel anti-melanoma treatment: focus on immunotherapy.Influence of genetic variants in type I interferon genes on melanoma survival and therapy.STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients.IFN-α in the treatment of melanomaPhase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and ProgressionTumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cellsSTAT1 and STAT3 in tumorigenesis: A matter of balance.Type I interferons: key players in normal skin and select cutaneous malignancies.Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon.Role of interferon in melanoma: old hopes and new perspectives.Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patientsMelanoma & biomarkers of immunoresponsiveness
P2860
Q30413226-A8E88388-5C53-48AC-B643-B14F97E22F79Q34309404-C000A01B-8A47-4EFE-B37D-158126BDADE6Q34500626-166E7F14-4788-4561-BF85-04986DF3A378Q34931400-F1F5CF24-250E-439D-8C1A-B409EDE4C142Q35572008-EDABEC9C-F90F-4F20-A79B-C39FBC29D21DQ36687470-8B461E3F-6571-49BF-8C19-0852B7BC280AQ36784394-EE81A36D-B664-4847-B0A0-D564E0B179EBQ36796779-1BD049B2-8375-4B78-B943-6F92D58F9E30Q38140881-E5EC99B1-CEF3-4E68-8714-D43E189961D1Q38187119-F610D96F-59DE-4E52-B652-64A96BD4C202Q38195330-23C997AC-DB2F-44AE-B3B8-4070D8FB0DD9Q39168894-65420F38-50D5-48F9-B159-4D2821E94267Q51035013-97C5686D-D356-4086-A9A6-F6FC0D8BA722Q56897846-6529714E-2EBD-494F-9891-0A1551611888Q58234468-76D2DBED-3F47-4FA7-B8BF-538B4C1A62F0
P2860
Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interferon signaling patterns ...... n therapy in melanoma patients
@en
type
label
Interferon signaling patterns ...... n therapy in melanoma patients
@en
prefLabel
Interferon signaling patterns ...... n therapy in melanoma patients
@en
P2093
P2860
P356
P1476
Interferon signaling patterns ...... n therapy in melanoma patients
@en
P2093
Diana L Simons
Gerald Lee
John M Kirkwood
Peter P Lee
P2860
P2888
P356
10.1186/1479-5876-9-52
P577
2011-05-05T00:00:00Z
P5875
P6179
1007192991